InflaRx IFRX
NASDAQ IFRX
$1.57 +0.03 (+1.62%)
As of: Oct 21, 2026 · 10:10 AM EDT

InflaRx (IFRX) Non-Current Debt (2025 - 2026)

Updated

InflaRx (IFRX) posted Non-Current Debt of $5.15 million for Q2 2025.

Analysis

InflaRx (IFRX) Non-Current Debt (2025 - 2026) Analysis & Trends

Since Q2 2019, InflaRx has reported Non-Current Debt for 5 quarters.

  • The Q2 2025 figure stands as the lowest quarterly Non-Current Debt since Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,130.97 Bn 1,099.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 614.97 Bn 533.50 Bn 17.26 Bn 37.34 Bn
3 AbbVie 505.56 Bn 478.67 Bn 12.70 Bn 62.48 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.80 Bn 261.79 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.62 Bn 235.31 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.78 Bn 191.18 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 189.91 Bn 164.11 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 InflaRx 105.31 Mn -228.31 Mn 2.74 Mn 89,315.88
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 6.02 Mn
Dec 31, 2025 6,815.93 Bn
Jun 30, 2025 5.34 Mn
API Access

InflaRx Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=IFRX&period=max&api_key=YOUR_API_KEY